Detalhe da pesquisa
1.
Tumor monocyte content predicts immunochemotherapy outcomes in esophageal adenocarcinoma.
Cancer Cell
; 41(7): 1222-1241.e7, 2023 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433281
2.
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent Glioblastoma.
Clin Cancer Res
; 28(12): 2567-2578, 2022 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395080
3.
A phase 1 study of NY-ESO-1 vaccine + anti-CTLA4 antibody Ipilimumab (IPI) in patients with unresectable or metastatic melanoma.
Oncoimmunology
; 10(1): 1898105, 2021 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33796406
4.
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.
Clin Cancer Res
; 26(13): 3193-3201, 2020 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32205463